340 related articles for article (PubMed ID: 22398095)
1. Infliximab-induced psoriasis during therapy for Crohn's disease.
Steinwurz F; Denadai R; Saad-Hossne R; Queiroz ML; Teixeira FV; Romiti R
J Crohns Colitis; 2012 Jun; 6(5):610-6. PubMed ID: 22398095
[TBL] [Abstract][Full Text] [Related]
2. Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases.
Famenini S; Wu JJ
J Drugs Dermatol; 2013 Aug; 12(8):939-43. PubMed ID: 23986169
[TBL] [Abstract][Full Text] [Related]
3. Infliximab-associated psoriasis in children with Crohn's disease may require withdrawal of anti-tumor necrosis factor therapy.
Broge T; Nguyen N; Sacks A; Davis M
Inflamm Bowel Dis; 2013 Apr; 19(5):E75-7. PubMed ID: 23435403
[No Abstract] [Full Text] [Related]
4. [Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease].
Avila Alvarez A; García-Alonso L; Solar Boga A; García-Silva J
An Pediatr (Barc); 2009 Mar; 70(3):278-81. PubMed ID: 19409245
[TBL] [Abstract][Full Text] [Related]
5. Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab.
Andrisani G; Marzo M; Celleno L; Guidi L; Papa A; Gasbarrini A; Armuzzi A
Eur Rev Med Pharmacol Sci; 2013 Oct; 17(20):2831-6. PubMed ID: 24174369
[TBL] [Abstract][Full Text] [Related]
6. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis induced by infliximab in a patient suffering from Crohn's disease.
Manni E; Barachini P
Int J Immunopathol Pharmacol; 2009; 22(3):841-4. PubMed ID: 19822070
[TBL] [Abstract][Full Text] [Related]
8. Psoriasiform and pustular eruption induced by infliximab.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
[TBL] [Abstract][Full Text] [Related]
9. Guttate psoriasis induced by infliximab in a child with Crohn's disease.
Costa-Romero M; Coto-Segura P; Suarez-Saavedra S; Ramos-Polo E; Santos-Juanes J
Inflamm Bowel Dis; 2008 Oct; 14(10):1462-3. PubMed ID: 18383177
[No Abstract] [Full Text] [Related]
10. Development of diffuse alopecia with psoriasis-like eruptions during administration of infliximab for Crohn's disease.
Kawashima K; Ishihara S; Yamamoto A; Ohno Y; Fukuda K; Onishi K; Kinoshita Y
Inflamm Bowel Dis; 2013 Mar; 19(3):E33-4. PubMed ID: 22508420
[No Abstract] [Full Text] [Related]
11. [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
Sansó Sureda A; Rocamora Durán V; Sapiña Camaró A; Royo Escosa V; Bosque López MJ
Gastroenterol Hepatol; 2011 Oct; 34(8):546-50. PubMed ID: 21665330
[TBL] [Abstract][Full Text] [Related]
12. [A case of psoriasis induced by infliximab treatment for Crohn's disease].
Jwa YJ; Kim NH; Park HJ; Park JS; Bae WK; Kim KA; Lee JS; Moon YS
Korean J Gastroenterol; 2010 Nov; 56(5):324-8. PubMed ID: 21099241
[TBL] [Abstract][Full Text] [Related]
13. Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease.
Weizman AV; Sharma R; Afzal NM; Xu W; Walsh S; Stempak JM; Nguyen GC; Croitoru K; Steinhart AH; Silverberg MS
Dig Dis Sci; 2018 Sep; 63(9):2430-2438. PubMed ID: 29736839
[TBL] [Abstract][Full Text] [Related]
14. The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series.
Afzali A; Wheat CL; Hu JK; Olerud JE; Lee SD
J Crohns Colitis; 2014 Jun; 8(6):480-8. PubMed ID: 24268978
[TBL] [Abstract][Full Text] [Related]
15. [Psoriasis induced by infliximab].
Fernandes IC; Torres T; Sanches M; Velho G; Lago P; Selores M
Acta Med Port; 2011 Dec; 24 Suppl 3():709-12. PubMed ID: 22856418
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease--what is the role of anti-TNF antibody?
Farkas K; Nagy F; Kovács L; Wittmann T; Molnár T
J Crohns Colitis; 2013 May; 7(4):e143-5. PubMed ID: 22818164
[TBL] [Abstract][Full Text] [Related]
18. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.
Fréling E; Baumann C; Cuny JF; Bigard MA; Schmutz JL; Barbaud A; Peyrin-Biroulet L
Am J Gastroenterol; 2015 Aug; 110(8):1186-96. PubMed ID: 26195181
[TBL] [Abstract][Full Text] [Related]
19. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
20. Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature.
Sisman G; Erzin Y; Bal K
J Crohns Colitis; 2013 Oct; 7(9):e397-8. PubMed ID: 23583098
[No Abstract] [Full Text] [Related]
[Next] [New Search]